STOCK EXCHANGE: Bittium became NATO’s favorite and Tecnotree’s shares became a buyout offer

On the Helsinki Stock Exchange, the day was electrified by Tecnotree’s purchase offer, Bittium’s NATO deal and two results announcements. Describing the general development of the Helsinki Stock Exchange OMXH-index ended up 0.7 percent to 12888.57 points.

The pace of US international policy has been frowned upon in global markets. Uncertainty has weakened the dollar and made gold more expensive.

They ended up at the top of the list with an increase of more than one percent Nordic, Nokian, Wärtsilä and Metson stocks.

Having been in a frenzy Sotkamo Silverin the share price ended on Tuesday with a decrease of 2.7 percent.

Of the results publishers, the asset manager your marriage turnover rose to 38.1 million euros in October-December from 30.1 million euros a year ago. Adjusted operating profit improved to 15.7 million euros from 10.6 million. The numbers were clearly better than the 31.3 and 11.8 million predicted by Inderes, the only company that follows the company.

Evli’s share price rose by 5.6 percent to 26.50 euros.

A fur company Furs Saga announced the financial statements and the May-October interim report. The turnover for the half-year increased to 28.7 million euros from 26.8 million and the operating result improved to 4.8 million euros from 3.1 million.

The Saga Furs share price rose by 2.9 percent to 8.95 euros.

It was the morning’s strongest riser Tecnotreefrom which a purchase offer was received. The share price rose by 40.5 percent to 5.62 euros, while the offer price is 5.70 euros.

CEO involved in Tecnotree’s buyer consortium

of Helios, Fitzroyn and Padma Ravichanderin formed by the consortium has made a purchase offer for all issued and outstanding shares of Tecnotree, as well as all issued securities entitling to shares.

According to Tecnotree’s press release, the shares are offered at EUR 5.70 per share. The total value of the purchase offer is approximately EUR 131 million, including shares and securities.

The offer represents a 42.5 percent premium to Monday’s closing price, which was EUR 4.00. In the fall, the company’s share was worth more than five euros.

Tecnotree’s board of directors recommends accepting the purchase offer.

Ravichander is the CEO of Tecnotree and the company’s second largest owner. Helios and Fitzroy are private investment companies. Tecnotree’s current largest owner, Fitzroy, is owned by Tecnotree’s chairman Neil Macleod and board member Conrad Neil Phoienix. The consortium will be controlled by a private limited company Resilience Investment Holdings.

Fitzroy and Ravichander’s engagements together From Luminos together with the received commitment represent a total of approximately 50.4 percent of all shares.

An investor who is one of the major owners of Tecnotree Kyösti Kakkonen assessed in an interview with Kauppalehti that the offer price should be clearly higher than what is currently presented. Kakkone holds 5.4 percent of Tecnotree’s shares.

Bittium is NATO’s recommended supplier

Providing secure communication solutions Bittium has contracted WE with the Information Systems Agency (NCIA) on the procurement framework of the contract. The agreement facilitates the sale of Bittium’s information security solutions to the NATO Information Systems Agency and member countries.

Bittium’s share price rose by 7.65 percent to 42.90 euros.

With the agreement, Bittium is a recommended supplier for the agency and NATO member countries, who can quickly acquire smartphones, software and additional devices for secure mobile communication.

Merus Power has entered into an electricity storage deal with Neve Oy worth approximately EUR 13 million. The share price rose by 6.4 percent to 4.48 euros.

Fred Larsen has been appointed Lamor Corporationin as CEO, and Johan Grön moves Lamor Recycling Oyas CEO of . The share price rose by 5.4 percent to 1.275 euros.

A drug development company focusing on the treatment of cancers with new immunotherapies Pharaoh announced that it is expanding its bexmarilimab program. The share price rose by 1.5 percent to 1.928 euros.